Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluating the effect of Valerian on irritable bowel syndrome
IRCT20210427051098N3Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Oct 2023
- Countries
- 1
01
Overview
Phase 3 trial of valeriana officinalis in irritable bowel syndrome (IBS), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoints: Symptom severity in irritable bowel syndrome and Quality of life in irritable bowel syndrome. Started Oct 2023; status: completed.
02
Drugs
valeriana officinalis
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on IRCT20210427051098N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210427051098N3.